Linda R. Duska, Kalyan Banda, Ana Oaknin, Vincent Ribrag, Antonio Gonzalez Martin, Nehal J. Lakhani, Jung-Yun Lee, Alok Tewari, Susana N. Banerjee, Maria-Pilar Barretina-Ginesta, Valentina Boni, Mehdi Brahmi, Lauriane Eberst, Jae Hoon Kim, Nicoletta Colombo, Domenica Lorusso, Nicola Faulhaber, Lennart Kann, Anjali Thakur, Charles Drescher. "Phase II dose optimization update with EZH2/EZH1 inhibitor tulmimetostat in patients with
            <i>ARID1A</i>
            -mutated ovarian clear cell carcinoma or endometrial carcinoma.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.3102